Annual Cash & Cash Equivalents:
$328.20M-$277.50M(-45.81%)Summary
- As of today, DBD annual cash & cash equivalents is $328.20 million, with the most recent change of -$277.50 million (-45.81%) on December 31, 2024.
- During the last 3 years, DBD annual cash & cash equivalents has fallen by -$95.00 million (-22.45%).
- DBD annual cash & cash equivalents is now -54.21% below its all-time high of $716.80 million, reached on December 31, 2016.
Performance
DBD Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$280.00M-$30.40M(-9.79%)Summary
- As of today, DBD quarterly cash & cash equivalents is $280.00 million, with the most recent change of -$30.40 million (-9.79%) on September 30, 2025.
- Over the past year, DBD quarterly cash & cash equivalents has dropped by -$65.70 million (-19.00%).
- DBD quarterly cash & cash equivalents is now -87.19% below its all-time high of $2.19 billion, reached on June 30, 2016.
Performance
DBD Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DBD Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -45.8% | -19.0% |
| 3Y3 Years | -22.4% | +95.8% |
| 5Y5 Years | +12.8% | -1.4% |
DBD Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -45.8% | at low | -53.8% | +95.8% |
| 5Y | 5-Year | -45.8% | +12.8% | -53.8% | +95.8% |
| All-Time | All-Time | -54.2% | +324.6% | -87.2% | +1683.4% |
DBD Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $280.00M(-9.8%) |
| Jun 2025 | - | $310.40M(-5.5%) |
| Mar 2025 | - | $328.30M(+0.0%) |
| Dec 2024 | $328.20M(-45.8%) | $328.20M(-5.1%) |
| Sep 2024 | - | $345.70M(-6.3%) |
| Jun 2024 | - | $368.80M(-9.5%) |
| Mar 2024 | - | $407.30M(-32.8%) |
| Dec 2023 | $605.70M(+76.2%) | $605.70M(+32.6%) |
| Sep 2023 | - | $456.90M(-17.3%) |
| Jun 2023 | - | $552.80M(+110.2%) |
| Mar 2023 | - | $263.00M(-23.5%) |
| Dec 2022 | $343.70M(-18.8%) | $343.70M(+140.3%) |
| Sep 2022 | - | $143.00M(-49.2%) |
| Jun 2022 | - | $281.30M(+5.4%) |
| Mar 2022 | - | $266.80M(-37.0%) |
| Dec 2021 | $423.20M(+17.0%) | $423.20M(+84.3%) |
| Sep 2021 | - | $229.60M(-1.2%) |
| Jun 2021 | - | $232.40M(-9.3%) |
| Mar 2021 | - | $256.10M(-29.2%) |
| Dec 2020 | $361.70M(+24.3%) | $361.70M(+27.3%) |
| Sep 2020 | - | $284.10M(-37.6%) |
| Jun 2020 | - | $455.40M(-13.4%) |
| Mar 2020 | - | $525.60M(+80.7%) |
| Dec 2019 | $290.90M(-40.9%) | $290.90M(+11.7%) |
| Sep 2019 | - | $260.50M(-4.5%) |
| Jun 2019 | - | $272.90M(-33.3%) |
| Mar 2019 | - | $409.40M(-16.8%) |
| Dec 2018 | $491.90M(-21.2%) | $491.90M(+9.6%) |
| Sep 2018 | - | $448.70M(+43.1%) |
| Jun 2018 | - | $313.50M(-18.8%) |
| Mar 2018 | - | $386.30M(-38.2%) |
| Dec 2017 | $624.60M(-12.9%) | $624.60M(+40.5%) |
| Sep 2017 | - | $444.70M(-15.8%) |
| Jun 2017 | - | $528.20M(-7.0%) |
| Mar 2017 | - | $567.80M(-20.8%) |
| Dec 2016 | $716.80M(+102.8%) | $716.80M(-9.0%) |
| Sep 2016 | - | $788.10M(-63.9%) |
| Jun 2016 | - | $2.19B(+364.5%) |
| Mar 2016 | - | $470.40M(+33.1%) |
| Dec 2015 | $353.50M(-22.9%) | $353.50M(+18.7%) |
| Sep 2015 | - | $297.70M(-18.2%) |
| Jun 2015 | - | $363.90M(+6.6%) |
| Mar 2015 | - | $341.50M(-25.5%) |
| Dec 2014 | $458.67M(-3.2%) | $458.67M(+22.6%) |
| Sep 2014 | - | $374.23M(-0.4%) |
| Jun 2014 | - | $375.83M(-11.8%) |
| Mar 2014 | - | $426.21M(-10.0%) |
| Dec 2013 | $473.70M(-24.9%) | $473.70M(+16.8%) |
| Sep 2013 | - | $405.62M(-22.9%) |
| Jun 2013 | - | $526.01M(-12.0%) |
| Mar 2013 | - | $597.41M(-5.3%) |
| Dec 2012 | $630.68M(+1.6%) | $630.68M(+10.2%) |
| Sep 2012 | - | $572.16M(-3.3%) |
| Jun 2012 | - | $591.40M(-3.3%) |
| Mar 2012 | - | $611.49M(-1.5%) |
| Dec 2011 | $620.77M(+3.2%) | $620.77M(+31.5%) |
| Sep 2011 | - | $472.21M(-12.5%) |
| Jun 2011 | - | $539.97M(-2.2%) |
| Mar 2011 | - | $552.21M(-8.2%) |
| Dec 2010 | $601.78M(+19.0%) | $601.78M(+38.3%) |
| Sep 2010 | - | $435.28M(+13.6%) |
| Jun 2010 | - | $383.10M(-10.4%) |
| Mar 2010 | - | $427.57M(-15.5%) |
| Dec 2009 | $505.87M(+39.4%) | $505.87M(+31.4%) |
| Sep 2009 | - | $385.02M(+10.0%) |
| Jun 2009 | - | $350.10M(+7.6%) |
| Mar 2009 | - | $325.27M(-10.4%) |
| Dec 2008 | $362.82M | $362.82M(+9.9%) |
| Sep 2008 | - | $330.25M(+3.0%) |
| Jun 2008 | - | $320.60M(+20.6%) |
| Mar 2008 | - | $265.73M(+13.8%) |
| Sep 2007 | - | $233.60M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $231.61M(+22.1%) |
| Mar 2007 | - | $189.70M(-46.3%) |
| Dec 2006 | $353.38M(+35.5%) | $353.38M(+25.5%) |
| Sep 2006 | - | $281.56M(+32.3%) |
| Jun 2006 | - | $212.76M(-42.2%) |
| Mar 2006 | - | $368.42M(+41.3%) |
| Dec 2005 | $260.79M(+20.9%) | $260.79M(+28.7%) |
| Sep 2005 | - | $202.62M(+13.6%) |
| Jun 2005 | - | $178.36M(-0.9%) |
| Mar 2005 | - | $180.00M(-16.5%) |
| Dec 2004 | $215.70M(+22.5%) | $215.70M(+73.2%) |
| Sep 2004 | - | $124.54M(+0.8%) |
| Jun 2004 | - | $123.58M(-19.7%) |
| Mar 2004 | - | $153.88M(-12.6%) |
| Dec 2003 | $176.10M(+7.8%) | $176.10M(+41.3%) |
| Sep 2003 | - | $124.64M(-10.1%) |
| Jun 2003 | - | $138.68M(-4.7%) |
| Mar 2003 | - | $145.53M(-10.9%) |
| Dec 2002 | $163.35M(+30.0%) | $163.35M(+70.4%) |
| Sep 2002 | - | $95.84M(+1.1%) |
| Jun 2002 | - | $94.76M(-12.6%) |
| Mar 2002 | - | $108.37M(-13.8%) |
| Dec 2001 | $125.67M(+56.2%) | $125.67M(+33.0%) |
| Sep 2001 | - | $94.46M(+7.2%) |
| Jun 2001 | - | $88.11M(-16.8%) |
| Mar 2001 | - | $105.85M(+24.4%) |
| Sep 2000 | - | $85.06M(+36.4%) |
| Jun 2000 | - | $62.36M(+7.6%) |
| Mar 2000 | - | $57.98M(-3.8%) |
| Sep 1999 | - | $60.24M(-25.8%) |
| Mar 1999 | - | $81.17M(+9.6%) |
| Sep 1998 | - | $74.05M(+25.8%) |
| Jun 1998 | - | $58.87M(-1.5%) |
| Mar 1998 | - | $59.78M(+194.5%) |
| Dec 1997 | - | $20.30M(-31.9%) |
| Sep 1997 | - | $29.80M(+24.7%) |
| Jun 1997 | - | $23.90M(-28.9%) |
| Mar 1997 | - | $33.60M(+53.4%) |
| Dec 1996 | - | $21.90M(-16.4%) |
| Sep 1996 | - | $26.20M(-2.6%) |
| Jun 1996 | - | $26.90M(-24.6%) |
| Mar 1996 | - | $35.70M(+127.4%) |
| Dec 1995 | - | $15.70M(-63.2%) |
| Sep 1995 | - | $42.70M(-27.6%) |
| Jun 1995 | - | $59.00M(-11.3%) |
| Mar 1995 | - | $66.50M(+284.4%) |
| Dec 1994 | - | $17.30M(-24.1%) |
| Sep 1994 | - | $22.80M(-2.1%) |
| Jun 1994 | - | $23.30M(-44.5%) |
| Mar 1994 | - | $42.00M(+7.7%) |
| Dec 1993 | - | $39.00M(+62.5%) |
| Sep 1993 | - | $24.00M(-3.6%) |
| Jun 1993 | - | $24.90M(-38.1%) |
| Mar 1993 | - | $40.20M(+16.9%) |
| Dec 1992 | - | $34.40M(-15.7%) |
| Sep 1992 | - | $40.80M(+30.4%) |
| Jun 1992 | - | $31.30M(+1.6%) |
| Mar 1992 | - | $30.80M(+2.7%) |
| Dec 1991 | - | $30.00M(+23.0%) |
| Sep 1991 | - | $24.40M(-21.3%) |
| Jun 1991 | - | $31.00M(+21.1%) |
| Mar 1991 | - | $25.60M(-23.8%) |
| Dec 1990 | - | $33.60M(+22.6%) |
| Sep 1990 | - | $27.40M(-7.4%) |
| Jun 1990 | - | $29.60M(-14.0%) |
| Mar 1990 | - | $34.40M(-5.8%) |
| Dec 1989 | $80.44M(-12.2%) | $36.50M(-60.2%) |
| Dec 1988 | $91.60M(+8.8%) | $91.60M(+8.8%) |
| Dec 1987 | $84.20M(+2.9%) | $84.20M(+2.9%) |
| Dec 1986 | $81.80M(-19.4%) | $81.80M(-19.4%) |
| Dec 1985 | $101.50M(+31.3%) | $101.50M(+31.3%) |
| Dec 1984 | $77.30M | $77.30M |
FAQ
- What is Diebold Nixdorf, Incorporated annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Diebold Nixdorf, Incorporated?
- What is Diebold Nixdorf, Incorporated annual cash & cash equivalents year-on-year change?
- What is Diebold Nixdorf, Incorporated quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Diebold Nixdorf, Incorporated?
- What is Diebold Nixdorf, Incorporated quarterly cash & cash equivalents year-on-year change?
What is Diebold Nixdorf, Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of DBD is $328.20M
What is the all-time high annual cash & cash equivalents for Diebold Nixdorf, Incorporated?
Diebold Nixdorf, Incorporated all-time high annual cash & cash equivalents is $716.80M
What is Diebold Nixdorf, Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, DBD annual cash & cash equivalents has changed by -$277.50M (-45.81%)
What is Diebold Nixdorf, Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DBD is $280.00M
What is the all-time high quarterly cash & cash equivalents for Diebold Nixdorf, Incorporated?
Diebold Nixdorf, Incorporated all-time high quarterly cash & cash equivalents is $2.19B
What is Diebold Nixdorf, Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, DBD quarterly cash & cash equivalents has changed by -$65.70M (-19.00%)